IGF2 and breast cancer: Breaching of the basement membrane is one of the first steps in breast cancer invasive progression, and when modeling this process using Matrigel invasion chambers, we again found a clear reduction in MM231 cell invasion in the presence of the anti–IGF-II function-blocking antibody and IGFBP2 (Fig. 4K).